Viridis Biopharma Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 3.42 Cr
as on 16-11-2024
- Company Age 24 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 16-11-2024
- Satisfied Charges ₹ 17.29 Cr
as on 16-11-2024
- Revenue 12.62%
(FY 2023)
- Profit -126.69%
(FY 2023)
- Ebitda -3.28%
(FY 2023)
- Net Worth -1.51%
(FY 2023)
- Total Assets -7.62%
(FY 2023)
About Viridis Biopharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 3.42 Cr.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹17.29 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ashit Vora, Vishal Vora, Anirudh Mehta, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230MH2000PTC127016
- Company No.
127016
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jun 2000
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Viridis Biopharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashit Vora  | Managing Director | 06-Jun-2000 | Current |
| Anirudh Mehta | Managing Director | 06-Jun-2000 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishal Vora | Director | 01-Feb-2011 | Current |
| Anselm Desouza | Director | 06-Jun-2000 | Current |
| Purnima Mehta | Director | 01-Oct-2015 | Current |
| Dilip Mehta | Director | 06-Jun-2000 | Current |
| Harshad Vora | Director | 06-Jun-2000 | Current |
Financial Performance and Corporate Structure Insights of Viridis Biopharma.
Viridis Biopharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.62% increase. The company also saw a substantial fall in profitability, with a 126.69% decrease in profit. The company's net worth dipped by a decrease of 1.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Viridis Biopharma?
In 2023, Viridis Biopharma had a promoter holding of 100.00%. The company had 2 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Synergia Life Sciences Private LimitedActive 20 years 8 monthsAshit Vora and Dilip Mehta are mutual person
_PRIVATE_LIMITED.webp)
Shavo Norgren (India) Private LimitedActive 59 years 6 monthsAshit Vora, Vishal Vora and 1 more are mutual person
- Viridis Personal Care Private LimitedActive 13 years 5 months
Ashit Vora, Vishal Vora and 2 more are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 08 Nov 2019 | ₹4.00 Cr | Open |
Standard Chartered Bank Creation Date: 28 Feb 2015 | ₹1.21 Cr | Satisfied |
Bank Of Baroda Creation Date: 14 Nov 2014 | ₹5.36 Cr | Satisfied |
How Many Employees Work at Viridis Biopharma?
Viridis Biopharma has a workforce of 59 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Viridis Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Viridis Biopharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
